Your Next Steps If you think you might meet GLP-1 eligibility criteria, here's how to move forward: Schedule a consultation with a healthcare provider experienced in weight management and metabolic health
In 2021, the FDA granted approval to Novo Nordisk for another semaglutide under the brand Wegovy, for people who have obesity or are overweight and have other health problems, like heart disease
Some Dental Surgery Procedures done in a hospital setting (e.g., jaw surgery) What OHIP Does Not Cover While OHIP is comprehensive, there are important exclusions
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome
On the other hand, Mounjaro delivers even greater metabolic benefits, with studies showing up to 20% weight loss, making it a formidable contender for both diabetes and obesity treatment